Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance
Abstract The COVID-19 pandemic has created a public health crisis. Because SARS-CoV-2 can spread from individuals with pre-symptomatic, symptomatic, and asymptomatic infections, the re-opening of societies and the control of virus spread will be facilitated by robust surveillance, for which virus testing will often be central. After infection, individuals undergo a period of incubation during which viral titers are usually too low to detect, followed by an exponential viral growth, leading to a peak viral load and infectiousness, and ending with declining viral levels and clearance. Given the pattern of viral load kinetics, we model surveillance effectiveness considering test sensitivities, frequency, and sample-to-answer reporting time. These results demonstrate that effective surveillance depends largely on frequency of testing and the speed of reporting, and is only marginally improved by high test sensitivity. We therefore conclude that surveillance should prioritize accessibility, frequency, and sample-to-answer time; analytical limits of detection should be secondary..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
bioRxiv.org - (2022) vom: 30. Okt. Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Larremore, Daniel B. [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| doi: |
10.1101/2020.06.22.20136309 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI01821231X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI01821231X | ||
| 003 | DE-627 | ||
| 005 | 20230429100655.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200626s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2020.06.22.20136309 |2 doi | |
| 035 | |a (DE-627)XBI01821231X | ||
| 035 | |a (biorXiv)10.1101/2020.06.22.20136309 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Larremore, Daniel B. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract The COVID-19 pandemic has created a public health crisis. Because SARS-CoV-2 can spread from individuals with pre-symptomatic, symptomatic, and asymptomatic infections, the re-opening of societies and the control of virus spread will be facilitated by robust surveillance, for which virus testing will often be central. After infection, individuals undergo a period of incubation during which viral titers are usually too low to detect, followed by an exponential viral growth, leading to a peak viral load and infectiousness, and ending with declining viral levels and clearance. Given the pattern of viral load kinetics, we model surveillance effectiveness considering test sensitivities, frequency, and sample-to-answer reporting time. These results demonstrate that effective surveillance depends largely on frequency of testing and the speed of reporting, and is only marginally improved by high test sensitivity. We therefore conclude that surveillance should prioritize accessibility, frequency, and sample-to-answer time; analytical limits of detection should be secondary. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Wilder, Bryan |e verfasserin |4 aut | |
| 700 | 1 | |a Lester, Evan |e verfasserin |4 aut | |
| 700 | 1 | |a Shehata, Soraya |e verfasserin |4 aut | |
| 700 | 1 | |a Burke, James M. |e verfasserin |4 aut | |
| 700 | 1 | |a Hay, James A. |e verfasserin |4 aut | |
| 700 | 1 | |a Tambe, Milind |e verfasserin |4 aut | |
| 700 | 1 | |a Mina, Michael J. |e verfasserin |4 aut | |
| 700 | 1 | |a Parker, Roy |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2022) vom: 30. Okt. |
| 773 | 1 | 8 | |g year:2022 |g day:30 |g month:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1126/sciadv.abd5393 |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2020.06.22.20136309 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 30 |c 10 | ||